Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quehenberger, P.
Right arrow Articles by Nawroth, P. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quehenberger, P.
Right arrow Articles by Nawroth, P. P.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 9 1561-1570, Copyright © 2000 by American Diabetes Association

ARTICLES

Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells

P Quehenberger, A Bierhaus, P Fasching, C Muellner, M Klevesath, M Hong, G Stier, M Sattler, E Schleicher, W Speiser and PP Nawroth
Department of Medical and Chemical Laboratory Diagnostics, University of Vienna, Austria.

Incubation of bovine aortic endothelial cells (BAECs) with erythrocytes from patients with type 2 diabetes induced an increase in endothelin 1 (ET-1) production. The effect of erythrocytes on ET-1 synthesis was dependent on glycemic control. ET-1 levels after incubation with erythrocytes derived from patients with HbA(1c) levels <6% were just half the levels observed after incubation with erythrocytes from patients with HbA(1c) levels >8%. Nepsilon-(carboxymethyl)lysine (CML)-containing protein isolated from patients' erythrocytes induced ET-1, and CML-containing protein-dependent ET-1 induction was blocked by the recombinant decoy peptide soluble receptor for advanced glycation end products (AGEs), which comprises the NH2-terminal Ig domain of the receptor for AGEs. In vitro-generated AGEs induced ET-1 mRNA transcription (nuclear run-on assay and Northern blot) in a time- and dose-dependent manner. Transient transfection of BAECs with a chimeric construct containing the 5' promoter region of the ET-1 gene linked to a reporter gene confirmed that AGE induced ET-1 promoter activity. Electrophoretic mobility shift assay confirmed AGE-inducible binding of members of the nuclear factor-kappab (NF-kappaB) family to a potential binding site at -2,090 bp. Binding was functionally significant because overexpression of the cytoplasmic inhibitor of NF-kappaB or deletion of the NF-kappaB binding site reduced ET-1 induction, whereas overexpression of NF-kappaB p65 induced ET-1 even in the absence of AGEs. Thus, ET-1 transcription is controlled by the AGE-inducible redox-sensitive transcription factor NF-kappaB.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Immunol.Home page
Y. J. Kang, B. Kusler, M. Otsuka, M. Hughes, N. Suzuki, S. Suzuki, W.-C. Yeh, S. Akira, J. Han, and P. P. Jones
Calcineurin Negatively Regulates TLR-Mediated Activation Pathways
J. Immunol., October 1, 2007; 179(7): 4598 - 4607.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
K. de Leeuw, R. Graaff, R. de Vries, R. P. Dullaart, A. J. Smit, C. G. Kallenberg, and M. Bijl
Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus
Rheumatology, October 1, 2007; 46(10): 1551 - 1556.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. Chauhan, S. Hahn, S. Gartner, C. A. Pardo, S. K. Netesan, J. McArthur, and A. Nath
Molecular programming of endothelin-1 in HIV-infected brain: role of Tat in up-regulation of ET-1 and its inhibition by statins
FASEB J, March 1, 2007; 21(3): 777 - 789.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Morigi, S. Buelli, C. Zanchi, L. Longaretti, D. Macconi, A. Benigni, D. Moioli, G. Remuzzi, and C. Zoja
Shigatoxin-Induced Endothelin-1 Expression in Cultured Podocytes Autocrinally Mediates Actin Remodeling
Am. J. Pathol., December 1, 2006; 169(6): 1965 - 1975.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Andrassy, J. Igwe, F. Autschbach, C. Volz, A. Remppis, M. F. Neurath, E. Schleicher, P. M. Humpert, T. Wendt, B. Liliensiek, et al.
Posttranslationally Modified Proteins as Mediators of Sustained Intestinal Inflammation
Am. J. Pathol., October 1, 2006; 169(4): 1223 - 1237.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
J. Herrmann, L. O. Lerman, D. Mukhopadhyay, C. Napoli, and A. Lerman
Angiogenesis in Atherogenesis
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 1948 - 1957.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Circulation, August 8, 2006; 114(6): 597 - 605.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
M. Ohkita, M. Sugii, Y. Ka, A. Kitamura, T. Mori, T. Hayashi, M. Takaoka, and Y. Matsumura
Differential Effects of Different Statins on Endothelin-1 Gene Expression and Endothelial NOS Phosphorylation in Porcine Aortic Endothelial Cells.
Experimental Biology and Medicine, June 1, 2006; 231(6): 772 - 776.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch
Diabetes and Advanced Glycoxidation End Products.
Diabetes Care, June 1, 2006; 29(6): 1420 - 1432.
[Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
J. R. Wahl, N. J. Goetsch, H. J. Young, R. J. Van Maanen, J. D. Johnson, A. S. Pea, and A. Brittingham
Murine Macrophages Produce Endothelin-1 After Microbial Stimulation
Experimental Biology and Medicine, October 1, 2005; 230(9): 652 - 658.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. Morigi, S. Buelli, S. Angioletti, C. Zanchi, L. Longaretti, C. Zoja, M. Galbusera, S. Gastoldi, P. Mundel, G. Remuzzi, et al.
In Response to Protein Load Podocytes Reorganize Cytoskeleton and Modulate Endothelin-1 Gene: Implication for Permselective Dysfunction of Chronic Nephropathies
Am. J. Pathol., May 1, 2005; 166(5): 1309 - 1320.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
M. Woods, E. G. Wood, S. C. Bardswell, D. Bishop-Bailey, S. Barker, S. J. Wort, J. A. Mitchell, and T. D. Warner
Role for Nuclear Factor-{kappa}B and Signal Transducer and Activator of Transcription 1/Interferon Regulatory Factor-1 in Cytokine-Induced Endothelin-1 Release in Human Vascular Smooth Muscle Cells
Mol. Pharmacol., October 1, 2003; 64(4): 923 - 931.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. Debigare and S. R. Price
Proteolysis, the ubiquitin-proteasome system, and renal diseases
Am J Physiol Renal Physiol, July 1, 2003; 285(1): F1 - F8.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Chen, Z. A. Khan, M. Cukiernik, and S. Chakrabarti
Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications
Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1089 - E1097.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Schiekofer, M. Andrassy, J. Chen, G. Rudofsky, J. Schneider, T. Wendt, N. Stefan, P. Humpert, A. Fritsche, M. Stumvoll, et al.
Acute Hyperglycemia Causes Intracellular Formation of CML and Activation of ras, p42/44 MAPK, and Nuclear Factor {kappa}B in PBMCs
Diabetes, March 1, 2003; 52(3): 621 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
S. Chen, S. Mukherjee, C. Chakraborty, and S. Chakrabarti
High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1
Am J Physiol Cell Physiol, February 1, 2003; 284(2): C263 - C272.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Morcos, A. A.R. Sayed, A. Bierhaus, B. Yard, R. Waldherr, W. Merz, I. Kloeting, E. Schleicher, S. Mentz, R. F. Abd el Baki, et al.
Activation of Tubular Epithelial Cells in Diabetic Nephropathy
Diabetes, December 1, 2002; 51(12): 3532 - 3544.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Di Stefano, G. Caramori, T. Oates, A. Capelli, M. Lusuardi, I. Gnemmi, F. Ioli, K.F. Chung, C.F. Donner, P.J. Barnes, et al.
Increased expression of nuclear factor-{kappa}B in bronchial biopsies from smokers and patients with COPD
Eur. Respir. J., September 1, 2002; 20(3): 556 - 563.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Romeo, W.-H. Liu, V. Asnaghi, T. S. Kern, and M. Lorenzi
Activation of Nuclear Factor-{kappa}B Induced by Diabetes and High Glucose Regulates a Proapoptotic Program in Retinal Pericytes
Diabetes, July 1, 2002; 51(7): 2241 - 2248.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
K. C.B. Tan, W.-S. Chow, V. H.G. Ai, C. Metz, R. Bucala, and K. S.L. Lam
Advanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes
Diabetes Care, June 1, 2002; 25(6): 1055 - 1059.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
J. A. Beckman, M. A. Creager, and P. Libby
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
JAMA, May 15, 2002; 287(19): 2570 - 2581.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
P. Quehenberger, M. Exner, R. Sunder-Plassmann, K. Ruzicka, C. Bieglmayer, G. Endler, C. Muellner, W. Speiser, and O. Wagner
Leptin Induces Endothelin-1 in Endothelial Cells In Vitro
Circ. Res., April 5, 2002; 90(6): 711 - 718.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Bierhaus, S. Schiekofer, M. Schwaninger, M. Andrassy, P. M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al.
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-{kappa}B
Diabetes, December 1, 2001; 50(12): 2792 - 2808.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
P. Quehenberger, M. Exner, R. Sunder-Plassmann, K. Ruzicka, C. Bieglmayer, G. Endler, C. Muellner, W. Speiser, and O. Wagner
Leptin Induces Endothelin-1 in Endothelial Cells In Vitro
Circ. Res., April 5, 2002; 90(6): 711 - 718.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.